An investigational medication is what is being studied to see if symptoms improve while taking it. It is not yet approved for general use by regulatory authorities. This study uses an investigational medication called Riliprubart. The investigational medicine is injected in a vein or under the skin, either at the …
These clinical studies are investigating the safety and efficacy of an investigational medication for patients with moderate to severe COPD and who are either current smokers or have a history of smoking.
This study investigates warm autoimmune hemolytic anemia (wAIHA). Participants will be in the study for up to 24 weeks in the primary analysis period, followed by 28 weeks in an open-label period, and potentially up to 52 weeks in a long-term extension, depending on response. The purpose is to evaluate …
The purpose of this study is to investigate the treatment of asthma in adults who are considered high-risk. This study investigates the effects of an investigational medication compared to a placebo in people with asthma who are not currently eligible for biologic treatments.The study focuses on evaluating the safety, effectiveness, …
This study investigates airway inflammation in people aged 40 to 85 years with Chronic Obstructive Pulmonary Disease (COPD). The purpose of this study is to compare the effects of an investigational medication with a placebo on lung function and quality of life.Participants will receive either the investigational medication or a …
This study investigates the effects of an investigational medication on individuals with moderate-to-severe ulcerative colitis.The study aims to evaluate the safety and effectiveness of different doses of the investigational medication in achieving clinical remission in patients. Researchers are particularly interested in understanding how well the medication works and its safety …
This study investigates the effects of an investigational medication on adults with IgG4-related disease (IgG4-RD).The study focuses on evaluating the safety and effectiveness of the investigational medication by observing how it impacts disease activity and flare-ups in participants with IgG4-RD.Who can participate: Adults aged 18 and older with an adjudicated …
This study investigates the effectiveness and safety of an investigational medication given to young boys with hemophilia A or B.The study aims to evaluate how well the investigational medication works and how safe it is for children with this condition. It is important to understand the effects of the medication …
